CYTK Stock-Based Compensation
Cytokinetics Inc · Stock-Based Compensation
CYTK Stock-Based Compensation
Latest reported$96.80Mperiod ending
CYTK Stock-Based Comp ($0.00 → $96.80M)
Annual stock-based compensation
High-resolution chart · PNG
CYTK stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 112,286,000 | |
| 97,840,000 | |
| 72,065,000 | |
| 47,853,000 | |
| 26,832,000 | |
| 17,620,000 | |
| 10,759,000 | |
| 9,761,000 | |
| 9,028,000 | |
| 7,146,000 | |
| 4,567,000 | |
| 3,330,000 | |
| 3,597,000 | |
| 3,783,000 | |
| 3,069,000 | |
| 4,017,000 | |
| 4,906,000 | |
| 5,606,000 | |
| 4,643,000 | |
| 4,643,000 | |
| 1,427,000 | |
| 1,876,000 | |
| 0 | |
| 0 |